How long does it take for Adagrasib to be effective for lung cancer?

The efficacy of Adagrasib (Adagrasib) in lung cancer varies from individual to individual, with significant responses typically observed in some patients within weeks of starting treatment. However, the exact time to results may vary depending on the patient's specific condition, stage of disease, and other factors.

As a targeted drug, the mechanism of action of adagrasib is to specifically interfere with the abnormal cell signaling caused by KRAS G12C mutation, thereby inhibiting the proliferation and survival of cancer cells. This type of treatment, which targets specific mutations, allows some patients to experience a reduction in symptoms or shrinkage of their tumors in a short period of time.

However, it is important to note that individual patient responses may vary. Some patients may see tumor shrinkage within a short period of time, while others may take longer to experience significant results. Additionally, for some patients, the manifestation of efficacy may be slow and progressive, requiring monitoring over the continuation of treatment.

When evaluating the efficacy of adagrasib, doctors usually monitor the patient's condition through clinical examinations, imaging techniques (such asCTscans) and other related testing methods. Doctors will adjust treatment plans based on these data to ensure patients get the best results.

Overall, adagrasib, as a new therapeutic drug, provides a new treatment option for patients with KRAS G12C mutation-related non-small cell lung cancer. However, during treatment, close doctor-patient communication and regular monitoring remain important factors to ensure optimal outcomes.

Adagrasib is not currently available in the country, so patients cannot purchase it domestically and can only purchase adagrasib through overseas channels. Abroad, there is only the original American drug adagrasib, and the price is very high, as high as about 190,000 yuan.